Canada markets closed

Zymeworks Inc. (ZYME.TO)

Toronto - Toronto Delayed Price. Currency in CAD
Add to watchlist
33.10+0.53 (+1.63%)
At close: 3:58PM EDT
Sign in to post a message.
  • a
    arthur
    glad to see that Wells Fargo likes Zyme. l hope it eventually helps but l personally don’t trust Wells Fargo sorry .
  • a
    arthur
     wish the company was a little bit more forthcoming ,somethings not right obviously. Did they have a major setback somewhere? I try to be optimistic and wonder if this is a buying opportunity. Just not sure which way to go with this company anymore.
  • t
    tarance
    regret,regret,regret... thats all i feel involved with this stock.
  • m
    mullins
    When will it ever end?!
  • S
    Sam
    is it over ? what is this ?
  • S
    Sam
    why can't they just tell investors the truth. from 36 to 24 no news.
    management ?
  • a
    arthur
    did I miss a news story or something? The stock was $36.00 five days ago what’s going on anybody have any answers?
  • D
    Davebiotech
    This thing is a real dawg. Typically I don't invest in canadian co's. They don't perform as well as US co's. The pipeline and partners are all top notch.
  • t
    tarance
    where is this stock going ?
  • L
    Lina
    Hard to believe people are selling this, I have being in here for over 4 years, around $ 8
    Still holding
    mother of all biotech, as some analyst called it 4 years ago, will pay big one day.
    Just be patient, This was at $ 55 not long ago without recent news,
    MC only $ 1.6B
  • a
    arthur
    decent spike at lunchtime in volume and the stock began to trend downward . Has anybody seen any news release?
  • F
    Faisal
    They are building a new lab. Its going to be done by january, so accumulate the discounted price cauze they will do great next year
  • M
    Mark
    Two days of good clinical results.. This should be over 45
  • a
    arthur
    At the rate this stock is going down l wonder if it will become an attractive take over . As they claim to have so many great drugs in the pipe line.
  • a
    arthur
    Possibly a shelf offering announce after the bell of course.  l guess they looking to add some more money in their pockets .
  • s
    stocktargetadvisor
    $ZYME
    Maintains Raymond James Financial Strong Buy CAD 94
  • a
    arthur
    wonderful we just had a 52 week low😔
  • a
    arthur
    Can’t seem to figure out the stock. The news today seem pretty good with Janssen today yet stock goes down. Go figure!
  • a
    arthur
    Any opinion on the update of their drug ? It appears okay but l am not a scientist.
  • J
    JohnD
    DB commentary:
    Zymeworks (ZYME)

    Zymeworks wants to help bring patients home disease free, developing treatments for various forms of cancer as well as tumors. After gaining 187% year-to-date, the biotech company is definitely on the Street’s radar.

    During the ESMO Asia 2019, the company provided an update on the first part of the Phase 1 trial evaluating single-agent ZW25 in HER2+ cancers, not including breast cancer. The data demonstrated that response rates improved for colorectal cancer and gastroesophageal adenocarcinoma, with ZW25's safety profile still looking promising. Most noteworthy, however, was that one pancreatic cancer patient experienced a 100% decrease in target lesions.

    “Overall, we view the ESMO Asia update as continuing to support the broad activity of ZW25 monotherapy in HER2+ cancers, especially in HER2-high cancers, with a safety profile that appears highly amenable to combination approaches. Further, first responses in duodenal and pancreatic tumors expand the breadth of that clinical activity and provide more reasons for us to be enthusiastic with regard to the company,”